DK1828378T3 - Deacylering af LPS i gram-negative bakterier - Google Patents

Deacylering af LPS i gram-negative bakterier

Info

Publication number
DK1828378T3
DK1828378T3 DK05815467.5T DK05815467T DK1828378T3 DK 1828378 T3 DK1828378 T3 DK 1828378T3 DK 05815467 T DK05815467 T DK 05815467T DK 1828378 T3 DK1828378 T3 DK 1828378T3
Authority
DK
Denmark
Prior art keywords
deacylation
lps
gram
negative bacteria
bacteria
Prior art date
Application number
DK05815467.5T
Other languages
Danish (da)
English (en)
Inventor
Johannes Petrus Maria Tommassen
Der Ley Peter Andre Van
Jeroen Johannes Gerardus Geurtsen
Original Assignee
Staat Der Nederlanden Vert Door De Minister Van Vws Ministerie Van Volksgezondheit Welzijn En Sport
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Staat Der Nederlanden Vert Door De Minister Van Vws Ministerie Van Volksgezondheit Welzijn En Sport filed Critical Staat Der Nederlanden Vert Door De Minister Van Vws Ministerie Van Volksgezondheit Welzijn En Sport
Application granted granted Critical
Publication of DK1828378T3 publication Critical patent/DK1828378T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK05815467.5T 2004-12-17 2005-12-16 Deacylering af LPS i gram-negative bakterier DK1828378T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04078445 2004-12-17
PCT/NL2005/050081 WO2006065139A2 (en) 2004-12-17 2005-12-16 Deacylation of lps in gram negative bacteria

Publications (1)

Publication Number Publication Date
DK1828378T3 true DK1828378T3 (da) 2014-09-01

Family

ID=34928754

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05815467.5T DK1828378T3 (da) 2004-12-17 2005-12-16 Deacylering af LPS i gram-negative bakterier

Country Status (15)

Country Link
US (1) US8048433B2 (enExample)
EP (1) EP1828378B1 (enExample)
JP (1) JP5378685B2 (enExample)
CN (1) CN101203605B (enExample)
AU (1) AU2005317304B2 (enExample)
BR (1) BRPI0519923A8 (enExample)
CA (1) CA2590906C (enExample)
DK (1) DK1828378T3 (enExample)
ES (1) ES2493440T3 (enExample)
MX (1) MX2007007288A (enExample)
NO (1) NO340331B1 (enExample)
NZ (1) NZ555889A (enExample)
PL (1) PL1828378T3 (enExample)
PT (1) PT1828378E (enExample)
WO (1) WO2006065139A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2681924C (en) * 2007-03-26 2019-12-31 De Staat Der Nederlanden, Vert. Door De Minster Van Vws Improved vaccines against bordetella pertussis based on lps glycosyltransferase mutants
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
JP2015525794A (ja) 2012-08-06 2015-09-07 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法
US11052142B2 (en) 2013-06-04 2021-07-06 Petr G. Aparin Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)
US20160120967A1 (en) 2013-06-04 2016-05-05 Petr Gennadievich Aparin Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)
CA2919773A1 (en) 2013-08-05 2015-02-12 Glaxosmithkline Biologicals S.A. Combination immunogenic compositions
WO2015179270A2 (en) 2014-05-19 2015-11-26 Board Of Regents, The University Of Texas System Combinatorial platform for the display of surface adjuvants and antigens
CN104388368B (zh) * 2014-10-30 2017-02-15 四川农业大学 一株低内毒素大肠杆菌原核表达工程菌突变株及构建方法
KR102888356B1 (ko) * 2016-01-28 2025-11-19 인트라백 비.브이. 변형된 테트라-아실화된 나이세리아 lps
CN105567620B (zh) * 2016-01-29 2019-03-19 江南大学 一株产减毒类脂A的Cronobacter sakazakii突变株及其应用
CN105695540A (zh) * 2016-03-18 2016-06-22 辽宁成大生物股份有限公司 一种革兰氏阴性菌胞壁抗原的制备方法
CA3055757A1 (en) * 2017-03-13 2018-09-20 De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport Bordetella vaccines comprising lps with reduced reactogenicity
US11744884B2 (en) * 2017-05-15 2023-09-05 University Of Maryland, Baltimore Live Salmonella typhi vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof
AU2018379236B2 (en) * 2017-12-04 2025-02-27 Intravacc B.V. An improved process for producing outer membrane vesicles
WO2021228930A2 (en) * 2020-05-14 2021-11-18 Merck Patent Gmbh Methods and compositions for purifying adeno associated virus particles or adenoviruses
EP4208472A1 (en) 2020-09-04 2023-07-12 Intravacc B.V. Ompa mutations enhance omv production in bordetella pertussis
EP4169513A1 (en) 2021-10-19 2023-04-26 GlaxoSmithKline Biologicals S.A. Adjuvant composition comprising sting agonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH650681A5 (en) 1981-08-14 1985-08-15 Dso Pharmachim Whooping cough vaccine
WO1989001976A1 (en) * 1987-09-04 1989-03-09 Amgen Inc. Recombinant dna-derived bordetella toxin subunit analogs
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
HU219819B (hu) * 1992-08-18 2001-08-28 Dimminaco Ag/Sa/Ltd. Izolált polinukleotidok, ezeket tartalmazó Bordetella bronchiseptica törzs, és Bordetella bronchiseptica elleni vakcina
ES2180758T3 (es) * 1995-05-04 2003-02-16 Aventis Pasteur Vacunas de pertussis acelulares y metodos de preparacion de las mismas.
US6887483B2 (en) 1995-12-01 2005-05-03 University Of Iowa Research Foundation Non-toxic mutants of pathogenic gram-negative bacteria
CA2284586C (en) * 1997-04-01 2011-02-08 Ribi Immunochem Research, Inc. Aqueous immunologic adjuvant compositions of monophosphoryl lipid a
CA2264970A1 (en) 1998-03-10 1999-09-10 American Cyanamid Company Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria
DK1127137T4 (da) * 1998-11-03 2014-02-10 Nederlanden Staat LPS med reduceret toksicitet fra genetisk modificerede gram-negative bakterier
US6531131B1 (en) * 1999-08-10 2003-03-11 The United States Of America As Represented By The Department Of Health And Human Services Conjugate vaccine for Neisseria meningitidis
US20030113742A1 (en) * 2001-04-20 2003-06-19 University Of Iowa Research Foundation Methods and compositions for the modulation of biofilm formation

Also Published As

Publication number Publication date
CN101203605A (zh) 2008-06-18
CA2590906C (en) 2017-01-03
JP2008523805A (ja) 2008-07-10
AU2005317304A1 (en) 2006-06-22
US20080274145A1 (en) 2008-11-06
NO340331B1 (no) 2017-04-03
CA2590906A1 (en) 2006-06-22
CN101203605B (zh) 2016-01-27
WO2006065139A2 (en) 2006-06-22
ES2493440T3 (es) 2014-09-11
PL1828378T3 (pl) 2014-10-31
WO2006065139A3 (en) 2006-10-19
NO20073088L (no) 2007-09-17
US8048433B2 (en) 2011-11-01
MX2007007288A (es) 2008-02-25
EP1828378B1 (en) 2014-06-11
AU2005317304B2 (en) 2011-06-23
EP1828378A2 (en) 2007-09-05
NZ555889A (en) 2009-07-31
PT1828378E (pt) 2014-10-10
BRPI0519923A8 (pt) 2018-01-23
JP5378685B2 (ja) 2013-12-25
BRPI0519923A2 (pt) 2009-08-11

Similar Documents

Publication Publication Date Title
DK1828378T3 (da) Deacylering af LPS i gram-negative bakterier
PT1984021T (pt) Bactérias gram-negativas não tóxicas viáveis
EP1913800A4 (en) NANOELECTROMECHANICAL AND MICROELECTROMECHANICAL SENSORS AND ANALYZERS
DK1877568T3 (da) Hydrolysering af arabinoxylan
DE502006006338D1 (de) Ächen
DK2194043T3 (da) Fremgangsmåder
DE602005019202D1 (de) Schuppenglas
DK2377931T3 (da) Varianter af glycosidhydrolase
DE112006004277A5 (de) Glaszusammensetzung
EP1909094A4 (en) BOWL
BRPI0402807B1 (pt) estrutura de eixo
ES1068509Y (es) Estructura de pared
DE502005007322D1 (de) Einpresskontakt
DE602005001326D1 (de) Brille
DK1635847T3 (da) Behandling af symptomer forbundet med bakteriel vaginose
EP1934955A4 (en) ILLUMINATED SIGN
EP1869464A4 (en) RAGE-DIAPHANOUS INTERACTION AND CORRESPONDING COMPOSITIONS AND METHODS
AT500549B8 (de) Klärbecken
DE502006000024D1 (de) Integration von Feldgeräten in ein Automatisierungssystem
FR2886171B1 (fr) Pipette motorisee
FR2887909B1 (fr) Kit pose parpaings
DE112006004075A5 (de) Biologische Klärvorrichtung
FI7221U1 (fi) Ensiapulaukku
FI20060676A0 (fi) Siirrettävä selkeytin
SK4608U (sk) Stavebnica